---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-24-071174"
form_type: "8-K"
ticker: "ESLA"
cik: "0001844417"
company_name: "Estrella Immunopharma, Inc."
filed_at: "2024-08-20T23:59:59+00:00"
generated_at: "2026-05-31T08:30:19.710211+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Estrella Immunopharma appoints Hong Zhang as Chairperson and Board member

## Summary
- Hong Zhang appointed Chairperson and director effective Aug 14, 2024; board expands from 5 to 6.
- Ms. Zhang brings 25+ years financial and corporate strategy experience; previous Chairman Dr. Cheng Liu remains on board.
- Compensation: $5,000/quarter as director + $2,500/quarter as Chairperson; expenses reimbursed.
- Company also negotiating consulting agreement with entity owned by Ms. Zhang for Asian strategic initiatives; terms pending approval.
- Press release notes dosing of first patient in Phase I/II trial STARLIGHT-1 for EB103 in R/R B-cell NHL.

## SEC filing metadata
- accession: 0001213900-24-071174
- form_type: 8-K
- ticker: ESLA
- cik: 0001844417
- company_name: Estrella Immunopharma, Inc.
- filed_at: 2024-08-20T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1844417/000121390024071174/0001213900-24-071174-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1844417/000121390024071174/ea021197101-8k_estrella.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-24-071174
- JSON: https://secwatch.observer/filing/0001213900-24-071174.json
- Plain text: https://secwatch.observer/filing/0001213900-24-071174.txt

## Key facts
- Executive change
  Hong Zhang was appointed as Chairperson and a member of the Board of Directors at Estrella Immunopharma, Inc..
  - Action: appointed
  - Role: Chairperson and a member of the Board of Directors
  source text: On August 14, 2024, the Board of Directors of Estrella Immunopharma, Inc. (the “Company”) appointed Ms. Hong Zhang as Chairperson and a member of the Company’s Board of Directors (the “Board”), effective as of the same date.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1844417/000121390024071174/0001213900-24-071174-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.